SOCIAL PSYCHIATRY AND PSYCHIATRIC EPIDEMIOLOGY, published by Springer Heidelberg, is a leading journal in the fields of Epidemiology, Psychiatry, and Mental Health, as well as Social Psychology. With its origins dating back to 1988, the journal remains at the forefront of research, exploring the intricate relationship between social factors and mental health outcomes. The journal boasts impressive rankings, holding Q1 status in multiple categories for 2023, including a notable rank of #22 in the Health (social science) category on Scopus, highlighting its influential role in academia and practice. Although it operates on a subscription-based model, it is widely recognized for disseminating high-quality research, making vital contributions to public health policy and clinical practice. By actively promoting scholarly discourse and interdisciplinary collaboration, SOCIAL PSYCHIATRY AND PSYCHIATRIC EPIDEMIOLOGY serves as an essential resource for researchers, professionals, and students committed to advancing our understanding of the social determinants of mental health.

BMC Psychiatry is a leading open-access journal published by BMC, dedicated to advancing the field of psychiatry and mental health. With its E-ISSN 1471-244X, the journal has been at the forefront of disseminating high-quality research since its inception in 2001, and it proudly maintains a Q1 ranking among psychiatry and mental health journals, reflecting its significant impact and relevance within the research community. Based in the United Kingdom, BMC Psychiatry boasts a commendable Scopus ranking of #158 out of 567 in the psychiatry and mental health category, placing it in the 72nd percentile. The journal serves as a vital platform for scholars, clinicians, and students alike, providing them with access to groundbreaking studies, innovative methodologies, and emerging trends in mental health. By fostering a collaborative environment, BMC Psychiatry not only enriches the academic landscape but also contributes to evidence-based practice and policy in mental health care.

FORUM DER PSYCHOANALYSE, published by SPRINGER, is a distinguished German journal dedicated to the fields of Clinical Psychology and Psychiatry and Mental Health. With an ISSN of 0178-7667 and an E-ISSN of 1437-0751, this journal plays a crucial role in the dissemination of contemporary psychoanalytic theory and practice. Recognized with a Q3 ranking in both Clinical Psychology and Psychiatry and Mental Health for 2023, it serves as a vital resource for researchers and practitioners seeking to explore the intersection of psychoanalytic thought with current clinical practices and mental health paradigms. Since its inception in 1987, FORUM DER PSYCHOANALYSE has provided a platform for rigorous peer-reviewed articles, detailed case studies, and theoretical explorations, fostering a vibrant community of psychoanalysts and mental health professionals. As an essential publication for those engaged in psychoanalytic research and clinical applications, it upholds high scholarly standards while contributing to the ongoing discourse in mental health and psychoanalysis.

Neuropsychopharmacology Reports is a leading open-access journal published by WILEY, dedicated to advancing the fields of clinical psychology, pharmacology, psychiatry, and mental health. Established in 2018, the journal aims to disseminate high-quality research findings, critical reviews, and innovative methodologies that elucidate the complexities of neuropsychopharmacology in enhancing mental health outcomes. With an impressive impact indicated by its Q2 rankings in several categories including Clinical Psychology and Pharmacology (medical) as of 2023, Neuropsychopharmacology Reports stands out as a vital resource for researchers, professionals, and students keen on exploring the interplay between pharmacological interventions and psychological well-being. The journal’s open-access nature ensures that critical advancements in this rapidly evolving field are readily available to a global audience, fostering collaboration and discourse among scholars and practitioners alike. Building on its indexed status with Scopus, the journal is positioned as a noteworthy contributor to ongoing discussions and developments in psychiatry and medical pharmacology.

Psychoanalytic Psychotherapy is a distinguished journal published by Routledge Journals, Taylor & Francis Ltd, focusing on the intersection of psychoanalysis and psychotherapy. Established in the United Kingdom and spanning its influential discourse since 1985, the journal has become an essential resource for researchers, clinicians, and students in the fields of Clinical Psychology and Psychiatry and Mental Health. With an impact factor reflecting its critical role in contemporary mental health discussions, Psychoanalytic Psychotherapy is indexed in Scopus and proudly holds a Q3 ranking in both Clinical Psychology and Psychiatry categories. The journal aims to publish cutting-edge research, theoretical advancements, and clinical applications, fostering a deeper understanding of psychoanalytic principles in therapeutic settings. Although it does not offer Open Access, the journal remains crucial for professionals seeking to explore the latest insights and empirical findings in psychoanalytic therapy.

Sante Mentale au Quebec is a prominent journal dedicated to the exploration and dissemination of research in the fields of Clinical Psychology, Psychiatry, and Mental Health. Published by the Revue Sante Mentale Quebec, this journal has been serving the academic community since its inception, with converged publication years from 1990 to 1998 and from 2004 to 2024. Despite its current Q4 rankings in both Clinical Psychology and Psychiatry and Mental Health categories, Sante Mentale au Quebec remains a crucial platform for sharing innovative research and advancements in mental health care and psychology practices within Canada and beyond. Researchers, professionals, and students can engage with a variety of articles that encompass empirical studies, literature reviews, and theoretical discussions, contributing to the betterment of mental health outcomes. This journal plays an essential role in fostering dialogue and collaboration among mental health professionals, ultimately aiming to enhance the quality of mental health services.

European Journal of Psychiatry, published by Elsevier España SLU, is a prestigious journal in the field of Psychiatry and Mental Health. Established in 1987, the journal has consistently provided a platform for high-quality research that addresses the complexities of mental health issues. With an impact factor that continues to evolve, it currently holds a significant position within the discipline, ranking Q3 in the 2023 category of Psychiatry and Mental Health. The journal is indexed in Scopus, where it ranks #316/567, placing it in the 44th percentile, affirming its relevance and contribution to the field. Though the journal does not offer open access, it remains a critical resource for researchers, practitioners, and students seeking to stay abreast of pioneering discoveries and methodologies in psychiatry. The European Journal of Psychiatry is a vital link between innovative academic research and practical applications in the mental health sphere, making it an essential resource for advancing knowledge and improving mental health practices.

Psychiatry and Clinical Psychopharmacology, an open-access journal published by AVES since 2017, is dedicated to advancing the fields of psychiatric medicine and psychopharmacology. With an ISSN of 2475-0573 and an E-ISSN of 2475-0581, this journal aims to provide a platform for disseminating innovative research and clinical findings relevant to mental health professionals and researchers. Although it currently holds a Q3 ranking in Pharmacology (medical) and a Q4 ranking in Psychiatry and Mental Health according to the 2023 category quartiles, the journal has established itself as a significant contributor to evolving discussions in these critical fields. Based in the United Kingdom, the journal encompasses diverse topics, ranging from pharmacological treatments to novel therapeutic approaches in psychiatry, thereby appealing to a broad audience of clinicians, scientists, and students. The open-access model ensures that all research is readily available, fostering an environment of collaboration and knowledge-sharing as the journal converges until 2024 to encompass the latest advancements in both pharmacology and clinical psychopharmacology.

PSYCHIATRIC QUARTERLY, published by Springer, stands as a pivotal resource in the field of psychiatry and mental health since its inception in 1927. With a reputable Q2 categorization in Psychiatry and Mental Health for 2023, this journal ranks impressively at #77 out of 567 in Scopus, placing it in the top 86th percentile of its category. Covering a diverse range of topics related to mental health, PSYCHIATRIC QUARTERLY aims to disseminate rigorous research findings, theoretical advancements, and clinical insights that contribute to improved mental health practices and policies. Although it does not offer open access, it provides substantial value to researchers, professionals, and students through its comprehensive analyses and scholarly articles. Located in New York, United States, the journal serves as an essential platform for advancing the understanding and treatment of psychiatric disorders, making it an invaluable addition to any academic library or research portfolio.

ZEITSCHRIFT FUR PSYCHOSOMATISCHE MEDIZIN UND PSYCHOTHERAPIE, published by Vandenhoeck & Ruprecht GmbH & Co KG, is a prominent journal in the fields of psychosomatic medicine and psychotherapy. With a rich history spanning from 1996 to 2024, this journal serves as a vital platform for disseminating research and advancements within applied psychology, clinical psychology, and psychiatry. The journal is categorized in the Q3 quartile for 2023 across various disciplines, reflecting its ongoing relevance and contribution to the scientific community. Despite not currently offering open access, it remains accessible to researchers and professionals through institutional subscriptions and libraries. By bridging the gap between empirical research and clinical practice, ZEITSCHRIFT FUR PSYCHOSOMATISCHE MEDIZIN UND PSYCHOTHERAPIE enhances the understanding of psychological processes and their implications for mental health, making it an indispensable resource for academics, practitioners, and students dedicated to the advancement of psychosomatic health.